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Topical Application of Neuronal Nitric Oxide
Synthase Inhibitor Accelerates Cutaneous Barrier
Recovery and Prevents Epidermal Hyperplasia
Induced by Barrier Disruption
Kazuyuki Ikeyama1, Shigeyoshi Fuziwara1 and Mitsuhiro Denda1
The effect of nitric oxide (NO) on skin barrier recovery rate was evaluated in hairless mouse. Topical application
of an NO synthase (NOS) inhibitor and a neuronal nitric oxide synthase (nNOS) inhibitor accelerated the
barrier recovery after tape stripping, whereas application of an inducible NOS (iNOS) inhibitor had no effect.
After tape stripping, the barrier recovery in nNOS/ mice was significantly faster than in wild type. Topical
application of the NO donor S-nitroso-N-acetyl-D,L-penicillamine (SNAP) delayed the barrier recovery in hairless
mice. Immediately after barrier disruption on skin organ culture, NO release from the skin was significantly
increased. The increase was blocked by nNOS inhibitor, but not by iNOS inhibitor. Topical application of the
guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) accelerated the barrier recovery,
whereas SIN-1 chloride, a guanylyl cyclase activator, delayed the barrier recovery. In cultured human
keratinocytes, SNAP increased the intracellular calcium concentration. The increase was blocked by ODQ, but
not by the calcium channel-blocker nifedipine. In calcium-free medium, SNAP increased the intracellular
calcium concentration. Topical application of both nNOS inhibitor and ODQ also reduced the epidermal
hyperplasia induced by barrier disruption under low environmental humidity. These results suggest that NO
plays an important signaling role in cutaneous barrier homeostasis and in epidermal hyperplasia induced by
barrier disruption.
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INTRODUCTION
One of the most important roles of the skin for terrestrial
mammals is to act as a water-impermeable barrier, prevent-
ing excess transcutaneous water loss. A decline in barrier
function often parallels increased severity of clinical sympto-
matology (Elias and Feingold, 2001). When the stratum
corneum barrier is damaged, a series of homeostatic
processes is immediately accelerated, and acts to restore
the barrier (Elias and Feingold, 2001). These processes
include lipid synthesis, lipid processing, and the acceleration
of exocytosis of lamellar bodies that contain intercellular
lipids (Elias and Feingold, 2001). Previous studies suggested
that lamellar body secretion and barrier recovery are
influenced by the calcium gradient in the epidermis. We
found that influx of calcium ions into epidermal keratinocytes
reduced the secretion of epidermal lamellar bodies and
delayed barrier recovery (Denda et al., 2003). This result
suggested that the ion flux is critical for the first phase of the
barrier recovery process.
Nitric oxide (NO) is a cell-signaling molecule that has
both cytostatic and cytotoxic actions in skin (Bruch-Gerharz
et al., 1998; Weller, 2003). Taniuchi et al. (2001) indicated
that NO may be involved in the pathogenesis of erythema in
the skin of patients with atopic dermatitis. In psoriatic skin
that shows barrier dysfunction and epidermal hyperplasia,
NO is generated at high levels by epithelial keratinocytes in
response to IFN-g and TNF-a (Giustizieri et al., 2002). NO is
synthesized by three types of NO synthases (NOS), neuronal
NOS (nNOS), endothelial NOS (eNOS), and inducible NOS
(iNOS), all of which are expressed in the skin (Bruch-Gerharz
et al., 1998; Cals-Grierson and Ormerod, 2004). Ormerod
et al. (1998) demonstrated that nNOS was present through all
levels of epidermis, and iNOS staining was significantly
upregulated in psoriatic skin.
It has been demonstrated that NO is involved in calcium
dynamics. NO generated in endothelial cells and rat aortic
smooth muscle cells promotes cyclic GMP (cGMP) forma-
tion, leading to a decrease of intercellular calcium concen-
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tration ([Ca2þ ]i) (Kaur et al., 1998; Lau et al., 2000). In
contrast, endogenous NO promotes intercellular calcium
release from mitochondria in striatal neurons (Horn et al.,
2002).
Thus, we hypothesized that skin barrier homeostasis might
be improved by appropriate control of NO generation. In this
study, we first examined the effects of an NO synthase
inhibitor, an nNOS inhibitor, and an iNOS inhibitor on the
skin barrier recovery after barrier disruption in hairless
mouse. And we evaluated the barrier recovery rate after
barrier disruption in nNOS/ mice. Moreover, we examined
the effects of topical application of the NO donor S-nitroso-
N-acetyl-D,L-penicillamine (SNAP) on the skin barrier home-
ostasis in hairless mouse. We also evaluated the release of
NO after tape stripping of an organ culture, the effect of an
NO-sensitive guanylyl cyclase inhibitor and an activator on
the skin barrier recovery after barrier disruption in hairless
mouse, and the effect of SNAP, an NO-sensitive guanylyl
cyclase inhibitor and a calcium channel blocker on the
intracellular calcium dynamics of cultured human keratino-
cytes. Moreover, we examined the effects of topical applica-
tion of an nNOS inhibitor and an NO-sensitive guanylyl
cyclase inhibitor on epidermal hyperplasia induced by barrier
disruption under low environmental humidity in hairless
mice.
RESULTS
Figure 1 shows the effects of topical application of NO
synthase inhibitors on skin barrier recovery after tape
stripping. Topical application of L-NAME generally inhibits
NO synthesis, and nNOS inhibitor (No-propyl-L-arginine)
accelerated the barrier repair. Conversely, an iNOS inhibitor
did not affect the barrier recovery. These effects were seen at
1, 3, and 6 hours after the treatment. Furthermore, to confirm
the pharmacologic studies and definitively demonstrate the
role of nNOS, we evaluated the barrier recovery in nNOS/
mice. Before barrier disruption, there was no significant
difference in baseline between wild-type (WT)
(21.2571.32 mg/cm2) and nNOS/ mice (21.570.71 mg/
cm2). After tape stripping, the barrier recovery in nNOS/
mice was significantly faster than in WT mice (Figure 2).
Figure 3 shows that topical application of the NO donor
SNAP delayed skin barrier recovery. These results suggested
that NO released from nNOS is involved in the processes of
skin barrier recovery, and inhibition of nNOS activity
specifically accelerates the recovery.
To examine the NO production or release upon barrier
disruption, we examined the NO level in skin after tape
stripping. Figure 4 shows the NO production or release from
skin organ culture with or without tape stripping. The NO
level was increased at 30 minutes after the tape stripping.
These results suggested that the NO level was increased
immediately after barrier disruption. The increase was
blocked by the presence of nNOS inhibitor. On the other
hand, iNOS inhibitor did not affect (Figure 4).
To ascertain the effect of the NO-cGMP pathway on
barrier homeostasis, we examined the effects of guanylyl
cyclase inhibitors and an activator on barrier recovery after
tape stripping (Figure 5). Topical application of NS2028,
which is a general inhibitor of guanylyl cyclase, and 1H-
[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), which is
an NO-sensitive guanylyl cyclase inhibitor, accelerated the
barrier recovery. On the other hand, application of SIN, a
guanylyl cyclase activator, delayed the barrier recovery.
Intercellular calcium concentration, evaluated with fura-2
acetoxymethylester, was increased in human-cultured kera-
tinocytes in the presence of 300mM SNAP (Figure 6). The
increase induced by SNAP was blocked by 10 mM ODQ,
whereas 50 mM nifedipine did not affect it (Figure 6). In
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Figure 1. Effects of topical application of NOS inhibitors in hairless mice.
Topical application of L-NAME (NOS inhibitor) or nNOS inhibitor accelerated
the barrier recovery of hairless mice after tape stripping. One micromolar
solution of each reagent was applied on one flank, using two points per flank
and four animals per treatment. **Po0.001, ***Po0.0001 compared with
control. The error bar shows SD.
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Figure 2. Barrier recovery in nNOS knockout mice after barrier disruption.
After tape stripping, the barrier recovery in nNOS/ mice (n¼ 4) was
significantly faster than in WT mice (n¼ 4). ***Po0.0001 compared with WT
mice. The error bar shows SD.
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calcium-free medium, an increase of [Ca2þ ]i was induced by
SNAP (Figure 7). These results suggest that the increase of
Ca2þ induced by this NO donor might be a result of the
release of calcium from internal stores in endoplasmic
reticulum.
Topical application of an nNOS inhibitor and ODQ
prevented the epidermal hyperplasia induced by acetone
treatment under low environmental humidity. Representative
sections are shown in Figure 8. Figure 8a shows the
hyperproliferative epidermis treated with water after acetone
treatment under low humidity. Dark spots represent BrdU-
positive cells, which were increased on the epidermal basal
layer (Figure 8a). Topical application of 1 mM nNOS inhibitor
prevented the epidermal hyperplasia (Figure 8b). Application
of 1 mM ODQ also prevented the hyperplasia (Figure 8c).
Quantified results are shown in Figure 8d and e. Significant
reductions of epidermal proliferation and epidermal thickness
were observed on both nNOS inhibitor-treated and ODQ-
treated skin as compared with acetone-treated skin.
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Figure 3. Effect of topical application of NO donor in hairless mice. Topical
application of SNAP delayed the barrier recovery of hairless mice after tape
stripping. One millimolar solution of SNAP was applied on one flank, using
two points per flank and four animals per treatment. **Po 0.001,
***Po0.0001 compared with control. The error bar shows SD.
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Figure 4. NO was released from skin of hairless mice immediately after
barrier disruption. The NO level was significantly increased by tape stripping.
The increase was blocked by preincubation with nNOS inhibitor (100 mM), but
not with iNOS inhibitor (100 mM). Number of animals: n¼ 14 (control and
tape) and n¼ 12 (nNOS inhibitor and iNOS inhibitor). *Po0.05, **Po0.005,
***Po0.0005 compared with control. The error bar shows SD.
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Figure 5. Effects of topical application of inhibitors and activator of guanylyl
cyclase (GC) in hairless mice. Topical application of a GC inhibitor and an
NO-sensitive GC inhibitor accelerated the barrier recovery of hairless mice
after tape stripping. One micromolar solution of each reagent was applied on
one flank, using two points per flank and four animals per treatment.
***Po0.0001 compared with control. The error bar shows SD.
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Figure 6. SNAP increased the intracellular calcium concentration in
cultured keratinocytes. The increase was blocked by ODQ, whereas
nifedipine (NIF) had no effect. The vertical axis shows the ratio of relative
intensity (340/380 nm) after treatment to that before treatment. The number of
cells for each measurement was 50. ***Po0.0001 compared with control.
The error bar shows SD.
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DISCUSSION
In this study, we found that an nNOS inhibitor accelerated
the barrier recovery rate, whereas an iNOS inhibitor had no
effect on the barrier repair process. After tape stripping, the
barrier recovery in nNOS/ mice was significantly faster
than in WT mice. Topical application of an NO donor
delayed barrier recovery in hairless mice. Thus, NO released
from nNOS appears to play an important role in barrier
recovery immediately after barrier disruption.
NO is produced by three isoforms of NOS. The constitutive
isoforms, nNOS and eNOS, and the inducible isoform, iNOS,
are all expressed in the skin (Bruch-Gerharz et al., 1998).
Ormerod et al. (1998) observed strong nNOS staining in the
granular layer of epidermis in normal skin, whereas eNOS
staining was seen in the endothelium and weakly in the
epidermis. They also demonstrated that nNOS was expressed
throughout all levels of the epidermis in psoriatic lesions, and
iNOS was significantly upregulated in psoriatic lesional skin,
focally in keratinocytes. These findings suggest that nNOS and
iNOS may play key roles in skin barrier homeostasis (Cals-
Grierson and Ormerod, 2004). Thus, in this study, we focused
on nNOS and iNOS. But potentially, eNOS might also be
involved in skin homeostasis. Further studies are needed to
investigate the expression of each NOS isoform in the
epidermis in relation to skin pathology.
In this study, we evaluated NO release after tape stripping
in an organ culture (Figure 4). The tape-stripped skin showed a
significant increase of NO release compared with untreated
skin. The increase was blocked by nNOS inhibitor. However,
iNOS inhibitor did not prevent the increase of NO release after
tape stripping. nNOS is a calcium-dependent enzyme and
increased levels of intercellular Ca2þ activate the enzyme via
calmodulin, whereas iNOS is calcium-independent (Bruch-
Gerharz et al., 1998). Changes in calcium occur in response to
altered barrier function (Lee et al., 1992; Elias, 2005). Our
results suggest that nNOS is activated after barrier disruption,
and thus NO generated from nNOS rather than iNOS might be
associated with skin barrier recovery. In normal human skin,
nNOS was expressed in keratinocytes in the granular layer and
eccrine sweat glands (Ormerod et al., 1998; Cals-Grierson and
Ormerod, 2004; Sowden et al., 2005). Some studies have
indicated that nNOS is involved in epidermal homeostasis. For
example, NO derived from nNOS has been shown to be
involved in the modulation of skin proliferation and melano-
genesis (Romero-Graillet et al., 1997). It has also been
demonstrated that nNOS is expressed in keratinocytes at a
wound site (Boissel et al., 2004). Our data suggest an
involvement of NO generated from nNOS in barrier repair.
NO activates guanylyl cyclase, resulting in cGMP
production (Bredt and Snyder, 1989). The effects of NO in
cellular signaling are related to its ability to regulate Ca2þ
homeostasis through the activation of the NO-cGMP pathway
(Clementi, 1998). In our studies, acceleration of the barrier
recovery was induced by an NO-sensitive guanylyl cyclase
inhibitor, whereas the enhancement of cGMP synthesis
delayed barrier recovery (Figure 5). These results suggest that
the NO-cGMP pathway could be involved in skin barrier
homeostasis. We previously demonstrated that influx of
calcium into epidermal keratinocytes blocked lamellar body
secretion and delayed barrier recovery (Denda et al., 2003).
Previous studies suggested that cGMP affects the voltage-
gated calcium channel in aortic smooth muscle cells (Kaur
et al., 1998) and ganglion cells (Hirooka et al., 2000). Jiang
et al. (2001) demonstrated that the store-operated Ca2þ entry
pathway is regulated by cGMP in human hepatoma cells
(Jiang et al., 2001). In this study, treatment of primary human
keratinocyte cultures with the NO-donor SNAP increased the
[Ca2þ ]i (Figure 6). The increase was blocked by the guanylyl
cyclase inhibitor ODQ (Figure 6). However, the calcium
channel-blocker nifedipine did not prevent the increase of
[Ca2þ ]i induced by the NO donor (Figure 6). Figure 7 shows
the change in [Ca2þ ]i of primary human keratinocyte
cultured in calcium-free medium. Treatment of the keratino-
cyte cultures with the NO-donor SNAP increased the [Ca2þ ]i
(Figure 7). These results suggest that the increase of Ca2þ
induced by this NO donor might be attributed not to the
influx of Ca2þ through voltage-gated calcium channels, but
to the release of calcium from the internal store in
endoplasmic reticulum. Some signaling pathways that induce
the release of calcium from the internal store in keratinocytes
have been described (Rosenbach et al., 1993; Aoyama et al.,
1995; Biro et al., 1998). Further studies are needed to
investigate the signal pathway of intracellular calcium release
in the present case.
Topical application of the nNOS inhibitor No-propyl-L-
arginine or ODQ reduced the epithelial hyperproliferative
response induced by acetone treatment under low environ-
mental humidity (Figure 8). Treatments that accelerate barrier
repair tend to prevent epidermal hyperplasia (Denda et al.,
1997; Ashida et al., 2001). Barrier disruption induced
epidermal DNA synthesis (Proksch et al., 1991). However,
the calcium influx is also related to keratinocyte proliferation,
differentiation, and inflammatory responses (Yuspa et al.,
1988). During the terminal differentiation of keratinocytes,
lipid synthesis and cornified envelope formation are also
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Figure 7. SNAP increased the intracellular calcium concentration in the
cultured keratinocytes in calcium-free medium. The vertical axis shows the
ratio of relative intensity (340/380 nm) after treatment to that before treatment.
The number of cells for each measurement was 50. ***Po0.0001 compared
with control. The error bar shows SD.
1716 Journal of Investigative Dermatology (2007), Volume 127
K Ikeyama et al.
nNOS Inhibitor Accelerates Barrier Repair
induced by calcium (Watanabe et al., 1998). Rossi et al.
(2000) have shown that NO inhibits cornified envelope
formation in human keratinocytes. NO regulates the synthesis
of gene products involved in keratinocyte differentiation and
ceramide metabolism (Gallala et al., 2004). NO might play
important roles in the regulation of various physiological
events in skin homeostasis, via regulation of calcium
concentration in keratinocytes.
We speculate that barrier disruption activated nNOS in the
present experiments, and increased the NO level in the
epidermis. The NO increase induced cGMP generation,
leading to the release of calcium from the internal store in
epidermal keratinocytes. Consequently, the intracellular
calcium level increased in the epidermal keratinocytes and
delayed barrier repair. If this cascade is blocked, for example,
by inhibition of NO synthesis or guanylyl cyclase, barrier
recovery is accelerated. If these ideas are correct, there are
implications for new clinical methodology to treat dermatoses
such as psoriasis and atopic disease, which are characterized
by barrier dysfunction and epidermal hyperplasia.
MATERIALS AND METHODS
Materials
Male hairless mice were purchased from Hoshino Laboratory
Animals (Saitama, Japan). Male nNOS/ mice and C57BL/
6J 129 hybrid control were purchased from Jackson Laboratories
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Figure 8. The effect of topical application of nNOS inhibitor and ODQ on epidermal hyperplasia of hairless mice induced by barrier disruption under low
environmental humidity. In (a–c), representative sections are shown. Bar¼ 20mm. Acetone treatment increased DNA synthesis in the epidermal basal layer
(a: dark cells are BrdU-positive) and the increase was blocked by topical application of (b) nNOS inhibitor or (c) ODQ. Bar¼ 20 mm. (d and e) the levels of
epidermal DNA synthesis and the epidermal thickness in the same experiment are shown in. The number of BrdU-positive cells and the epidermal thickness was
increased by acetone treatment under dry conditions. The increase was blocked by the topical application of nNOS inhibitor and ODQ. ***Po0.0001
compared with control. The error bar shows SD.
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(Maine). All animals were employed between 7 and 10-week old. All
procedures for measuring skin barrier function, disrupting the barrier
and applying the sample were carried out under anesthesia. All
experiments were approved by the Animal Research Committee of
the Shiseido Research Center in accordance with the National
Research Council Guide (National Research Council, 1996). The
NOS inhibitor L-N(G)-nitro-L-arginine methyl ester (L-NAME), iNOS
inhibitor S-methylisothiourea, nNOS inhibitor (No-propyl-L-argi-
nine), general guanylyl cyclase inhibitor NS2028 (4H-8-bromo-
1,2,4-oxadiazolo[3,4-dibenz[b][1,4]oxazin-1-one), NO-sensitive
guanylyl cyclase inhibitor ODQ, and guanylyl cyclase activator
SIN (SIN-1 chloride) were purchased from Tocris (Bristol, UK). The
NO donor SNAP was purchased from Sigma (Sigma, Tokyo, Japan).
Total NO assay kit was purchased from IBL (Gunma, Japan). All the
other reagents were purchased from Wako (Osaka, Japan).
Cutaneous barrier function
Permeability barrier function was evaluated by measurement of
transepidermal water loss (TEWL) with an electric water analyzer, as
described previously (Denda et al., 1998). For barrier recovery
experiments, the flank skin on both sides was subjected to repeated
tape stripping until the TEWL reached 7–10 mg/cm2/hour, as
described previously (Denda et al., 1998). As for nNOS/ mice
and WT mice, the TEWL of the ears was measured over the same sites
at 1, 3, and 6 hours after tape stripping. This is because the hair
shaving may induce barrier disruption. Therefore, the ears that are
hairless parts were selected for TEWL measurements. Immediately
after barrier disruption, 100ml of aqueous solution containing 1mM
reagent or water alone (control) was applied to the treated area. We
did not apply the same reagent to both flanks. The areas were covered
with plastic membranes for 15 minutes and then the membranes were
removed. Two points on one flank were measured and 4–8 mice were
used to evaluate the effect of each treatment. We always disrupted the
barrier between 0700–0800 hours and carried out the measurements
of the barrier repair thereafter to avoid the influence of circadian
rhythm on the repair rate (Denda and Tsuchiya, 2000). TEWL was
measured over the same sites at 1, 3, and 6 hours after barrier
disruption. The barrier recovery results are expressed as percent
recovery, because of variations from day to day in the extent of barrier
disruption. In each animal, the percentage recovery was calculated
according to the following formula: (TEWL immediately after barrier
disruptionTEWL at indicated time point)/(TEWL immediately after
barrier disruptionbaseline TEWL) 100%.
Epidermal hyperplasia induced by barrier disruption under low
humidity
Hairless mice were kept separately in 7.2-l cages in which the
relative humidity was maintained at less than 10% with dry air as
described previously (Denda et al., 1998). The temperature was the
same in all cases (22–251C), and fresh air was circulated 100 times/
hour. Animals were kept out of the direct stream of air. During the
experiments, the animal’s behavior was not restricted. The level of
NH3 was always below 1 p.p.m. Animals were first kept in a dry
condition for 48 hours and then the skin on both flanks was treated
with acetone-soaked cotton balls, as described previously (Denda
et al., 1998). The procedure was terminated when TEWL reached
2.5–3.5 mg/cm2/hour. Immediately after the barrier disruption, 100 ml
of nNOS inhibitor and ODQ aqueous solution (1mM) was applied on
one side of the treated area. Water was applied on the other side.
Then the animals were again kept in the dry condition for 48 hours.
After the experiments, animals were killed with diethylether
inhalation and skin samples were taken from the treated areas.
One hour before killing, 20 ml/g body weight of BrdU 10 mM solution
was injected intraperitoneally. Untreated control mice were also
treated with BrdU at the same time. After fixation with 4%
paraformaldehyde, full thickness skin samples were embedded in
paraffin, sectioned (4 mm), and processed for hematoxylin and eosin
staining. On each section, five areas were selected at random; the
thickness of the epidermis was measured with an optical micro-
meter, and the mean value was calculated. For the assessment of
DNA synthesis, the sections were immunostained with anti-BrdU
antibodies. On each section, five areas were selected at random
from one section; the number of immunostained cells per 1 mm of
epidermis was counted and the epidermal thickness was measured
with an optical micrometer. The mean value was calculated.
Measurements were carried out in an observer-blinded fashion.
NO evaluation in hairless mouse epidermis
Four male hairless mice (7 to 10-week old) were killed by cervical
dislocation under anesthesia and skin samples were taken immedi-
ately from both flanks. Subcutaneous fat was removed with a scalpel
and the skin samples that contained epidermis and dermis were cut
into squares (1.5 1.5 cm2). The three pieces of skin from the two
flanks of each animal were placed, epidermis side upwards, in
separate 35-mm culture dishes kept in an ice/water bath, and one of
them was tape stripped four times. The other piece of skin was not
treated. One milliliter of phosphate-buffered saline was added to both
dishes, which were incubated for 30 minutes at 371C. After the
incubation, 50ml aliquots of the phosphate-buffered saline were
removed. NO released into the phosphate-buffered saline was
quantified using a total NO assay kit (Immuno-Biological Laboratories
Co. Ltd, Gunma, Japan), according to the manufacturer’s instruction.
Calcium dynamics in keratinocyte culture system
Cells and cell culture. Normal human epithelial keratinocytes
were purchased from Kurabo (Osaka, Japan). Normal human
epithelial keratinocytes were cultured in serum-free keratinocyte
growth medium, consisting of Humedia-KB2 (Kurabo, Osaka, Japan)
supplemented with bovine pituitary extract (0.4% vol/vol), human
recombinant epidermal growth (0.1 ng/ml), insulin (10 mg/ml), and
hydrocortisol (0.5 mg/ml). The medium was replaced every 2–3 days.
For the electrophysiological experiments, normal human epithelial
keratinocytes (passage 1–3 cells) were seeded onto collagen-coated
glass coverslips and used within 4 days.
Ca2þ imaging in single keratinocytes. Normal human epithelial
keratinocytes were grown to approximately 80–100% confluency on
collagen-coated cover glass chambers (Nalge Nunc, Naperville, IL).
Changes in [Ca2þ ]i in single cells were measured by the fura-2
method as described by Grynkiewicz et al. (1985) with minor
modifications (Koizumi et al., 1998). In brief, the culture medium
was replaced with a balanced salt solution (BSS) of the following
composition (mM): NaCl 150, KCl 5, CaCl2 1.8, MgCl2 1.2, HEPES
25, NaH2PO4 1.2, and D-glucose 10 (pH 7.4) or calcium-free BSS
which had the same composition as the above BSS with 1 mM EGTA
and no added CaCl2. Cells were loaded with 5mM fura-2
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acetoxymethylester (Molecular Probes, Eugene, OR) at room
temperature (21–231C) in BSS for 45 minutes, washed with BSS,
and incubated for a further 30 minutes to allow de-esterification of
the loaded dye. The cover slip was mounted on an inverted
epifluorescence microscope (IX70, TS Olympus, Tokyo, Japan),
equipped with a 75 W xenon lamp and band-pass filters of 340 and
380 nm. The image data, recorded by a high-sensivity CCD (charge-
coupled device) camera (ORCA-ER, Hamamatsu Photonics, Hama-
matsu, Japan) were evaluated with a Ca2þ analyzing system
(AQUACOSMOS/RATIO, Hamamatsu Photonics). SNAP (300 mM),
ODQ (10 mM), and nifedipine (50 mM) were dissolved in the BSS and
the cells were exposed to the solution by perfusion. We observed
four lots of pooled cells for each treatment. Each microscopic field
contained approximately 50–60 cells. Data were represented as the
ratio of fluorescence intensities at 340 and 380 nm.
Statistics. The results are expressed as the mean7SD. Statistical
differences between two groups were determined by use of the two-
tailed Student’s t-test. In the case of more than two groups,
differences were determined by analysis of variance (ANOVA) with
Fisher’s protected least significant difference.
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